Yukie Yoda

Saga University, Apple (Israel)

Papers

6

Total Citations

126

H-Index

4

About

Dr. Yukie Yoda is a pioneering robotic surgeon whose work is reshaping the landscape of minimally invasive gastrointestinal oncology. Her primary research focuses on the safe and effective implementation of robotic platforms—from the established da Vinci system to emerging technologies like the hinotori™—for the treatment of gastric and esophageal cancers. Dr. Yoda’s major contributions include providing the first large-scale, real-world evidence of robotic gastrectomy’s safety under Japan’s universal health insurance system, a study that has garnered 53 citations and informed national policy. She has also demonstrated the long-term oncologic equivalence of robotic versus laparoscopic gastrectomy for stage I/II gastric cancer (42 citations), a critical finding for surgical decision-making. Her work extends to esophagectomy, where she has compared robot-assisted and conventional minimally invasive approaches using rigorous propensity score matching, and has characterized the learning curve for complex chest procedures. Notably, Dr. Yoda has developed and described novel techniques, such as secure robotic transthoracic valvuloplastic esophagogastrostomy, to prevent post-surgical reflux. With a growing body of high-impact research, she is a leading voice in defining the future of robotic digestive surgery.

Research Focus

Key Achievements

4
H-Index
6
Papers
126
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Safe implementation of robotic gastrectomy for gastric cancer under the requirements for universal health insurance coverage: a retrospective cohort study using a nationwide registry database in Japan
53 citations · 2021
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Saga University, Apple (Israel)

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago